IL1B and pulmonary arterial hypertension: Ongoing research is investigating the content of inflammatory mediators in these cells, comparing healthy control- and PAH-BMDMs, and assessing whether targeting metabolism can prevent the release of pro-inflammatory cytokines such as IL-1β.